Related Experiment Video

Updated: Aug 24, 2026

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
08:17

Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure

Published on: August 25, 2017

New treatments for chronic obstructive pulmonary disease

Peter J Barnes1

  • 1National Heart and Lung Institute, Imperial College, School of Medicine, London, United Kingdom. p.j.barnes@imperial.ac.uk

Annali Dell'Istituto Superiore Di Sanita
|April 22, 2004
PubMed

Insights

New treatments for chronic obstructive pulmonary disease (COPD) are targeting inflammation and lung destruction. These investigational therapies aim to slow disease progression and potentially reverse lung damage in COPD patients.

Area of Science:

  • Pulmonary Medicine
  • Pharmacology
  • Inflammation Research

Background:

  • Chronic obstructive pulmonary disease (COPD) lacks treatments that halt its progression or reduce airway inflammation.
  • Current therapeutic options do not address the underlying inflammatory processes in small airways and lung parenchyma effectively.

Purpose of the Study:

  • To review emerging therapeutic strategies for COPD focused on modulating inflammation.
  • To highlight novel drug candidates in development for COPD targeting specific inflammatory pathways and tissue destruction.

Main Methods:

  • Review of current clinical development pipelines for COPD therapeutics.
  • Identification of drug targets including inflammatory mediators, oxidative stress pathways, and enzymes involved in lung tissue degradation.

Main Results:

  • Several novel anti-inflammatory agents are in clinical development, targeting mediators like leukotriene B4, interleukin-8, and tumor necrosis factor-alpha.
  • Inhibitors of phosphodiesterase-4, p38 MAP kinase, nuclear factor-kappaB, and phosphoinositide-3 kinase-gamma are under investigation.
  • Research is ongoing for elastase inhibitors to prevent emphysema and agents that may reverse lung destruction.

Conclusions:

  • New therapeutic avenues for COPD are emerging, focusing on anti-inflammatory mechanisms.
  • These investigational treatments offer potential to slow COPD progression and address lung tissue damage.
  • Further development is needed to bring these promising therapies to patients with COPD.

More Related Videos

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation09:42

Using Continuous Data Tracking Technology to Study Exercise Adherence in Pulmonary Rehabilitation

Published on: November 8, 2013

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...